Graeme M. Clark and colleagues describe the evolving science of cochlear implants and the histopathology associated with a patient who had his implant removed when it failed in 1983 and again in 1998. Dr Clark has been awarded the 2013 Lasker-DeBakey Clinical Medical Research Award for his pioneering work in cochlear implant development.
In 1978, the first multichannel cochlear implant was developed in Australia and a prototype was surgically implanted in a 48-year-old patient (MC-1). After a series of clinical trials, the US Food and Drug Administration approved the use of the Australian cochlear implant in adults in 1985, and subsequently, the agency has approved the device for use in infants as young as 6 months of age. During the past 3 decades, more than 300 000 patients have had their hearing restored with cochlear implants. In this Viewpoint, we describe how the assessment of the temporal bone of MC-1, the first patient to receive a cochlear implant, is aiding the further development of the device.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
A, Heterotopic bone formation (asterisk) and black particulate matter (black arrowhead) engulfed by macrophages in tissue surrounding the CI-24 electrode (Masson trichrome, original magnification x 40). B, Multinucleate giant cell (blue arrowhead) and macrophages containing foreign black particles (black arrowhead) in tissue surrounding the CI-22 electrode (hematoxylin-eosin, original magnification x 40).
Three-dimensional reconstruction (right) of the patient's cochlea from histologic sections shows the lateral position of the CI-24 electrode tract (orange). In future patients, a thin-film, high-density electrode microarray (green) could be placed in a perimodiolar position, closer to the spiral ganglion, for fine temporo-spatial patterns of nerve stimulation.7
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
JAMA 2013-09-09, Vol. 310, No. 12, Author Audio Interview (Published online September 09, 2013)
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.